Indiana Healthcare Today
SEE OTHER BRANDS

Get your fresh news on health and wellness in Indiana

Indiana Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.

Press releases published on September 2, 2025

Indiana Center for Recovery Recognized Among America’s Best Addiction Treatment Centers by Newsweek

Indiana Center for Recovery Recognized Among America’s Best Addiction Treatment Centers by Newsweek

Indiana Center for Recovery ranks among the top 3 in Indiana by Newsweek 2024 for excellence in addiction treatment and mental health services. BLOOMINGTON, IN, UNITED STATES, September 2, 2025 /⁨EINPresswire.com⁩/ -- Indiana Center for Recovery has been …

Facelift, Rhinoplasty, Eyelid Surgery: Zionsville Facial Plastic Surgeon Discusses the Most Popular Options

Facelift, Rhinoplasty, Eyelid Surgery: Zionsville Facial Plastic Surgeon Discusses the Most Popular Options

Dr. Emily Hrisomalos discusses the increasing popularity of facelift, rhinoplasty, and eyelid surgery and how those options can benefit patients. ZIONSVILLE, IN, UNITED STATES, September 2, 2025 /⁨EINPresswire.com⁩/ -- In the evolving field of facial …

Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference

LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and …

Flex Raises $15M to Unlock $150B in Untapped Pre-Tax Spending for Leading Health & Wellness Retailers

Flex Raises $15M to Unlock $150B in Untapped Pre-Tax Spending for Leading Health & Wellness Retailers

SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Flex, the leading platform that enables health and wellness brands to accept Health Savings Account (HSA) and Flexible Spending Account (FSA) payments, has raised $15 million in Series A funding, bringing …

Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors

Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …

Korro to Participate in Upcoming Investor and Scientific Conferences

Korro to Participate in Upcoming Investor and Scientific Conferences

CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's 2025 …

Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September

Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September

TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in September as follows: Morgan …

Nyxoah Announces Upcoming Investor Events

Nyxoah Announces Upcoming Investor Events

Nyxoah Announces Upcoming Investor Events Mont-Saint-Guibert, Belgium – September 2, 2025, 10:30pm CET / 4:30PM ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment …

Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs

Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs

Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs Mont-Saint-Guibert, Belgique – 2 septembre 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale …

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 54,360 restricted stock units (“RSUs”) and options to purchase 38,850 shares of the Company’s common stock to …

Sanara MedTech Inc. Announces Chief Executive Officer Transition

Sanara MedTech Inc. Announces Chief Executive Officer Transition

Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical …

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics’ President …

Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

PARIS and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for …

Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment

Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment

PARIS et CAMBRIDGE, Mass., 02 sept. 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les …

Certara to Participate in Upcoming Investor Conferences

Certara to Participate in Upcoming Investor Conferences

RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: Baird Global Healthcare …

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Lifecore Biomedical to Participate in Upcoming Investor Conferences

CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming …

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …

Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Berkeley, Calif, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an …

STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

HORSHAM, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions